Vivos Inc. (OTCMKTS:RDGL) Sees Significant Drop in Short Interest

Vivos Inc. (OTCMKTS:RDGL) saw a large decline in short interest during the month of June. As of June 30th, there was short interest totalling 26,800 shares, a decline of 41.7% from the June 15th total of 46,000 shares. Based on an average daily volume of 5,230,800 shares, the days-to-cover ratio is currently 0.0 days.

Vivos Stock Performance

RDGL remained flat at $0.19 during trading hours on Friday. The company had a trading volume of 285,482 shares, compared to its average volume of 1,860,329. The business has a fifty day moving average of $0.18 and a 200-day moving average of $0.12. The stock has a market cap of $77.36 million, a PE ratio of -18.50 and a beta of 1.01. Vivos has a 12-month low of $0.04 and a 12-month high of $0.26.

Vivos Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.